Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 20/20 | 0.63 |
| ▸ | APP | P05067 | 13/20 | 0.63 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.57 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.57 |
| ▸ | CTSD | P07339 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18561441 | 0.89 | BACE1 (0.65) | BACE1APPKCNH2BACE2CTSD | |
| SCHEMBL18561562 | 0.89 | BACE1 (0.65) | BACE1APPKCNH2BACE2CTSD | |
| SCHEMBL18927268 | 0.86 | BACE1 (0.58) | BACE1APPKCNH2BACE2 | |
| SCHEMBL18927120 | 0.83 | APP (0.61) | BACE1APP | |
| SCHEMBL21654446 | 0.83 | APP (0.63) | BACE1APP | |
| SCHEMBL21654456 | 0.83 | BACE1 (0.65) | BACE1APPKCNH2BACE2CTSD | |
| SCHEMBL18926536 | 0.82 | BACE1 (0.62) | BACE1APPKCNH2BACE2 | |
| SCHEMBL18926464 | 0.81 | BACE1 (0.60) | BACE1APPKCNH2BACE2CTSD | |
| SCHEMBL18927250 | 0.80 | BACE1 (0.59) | BACE1APP | |
| SCHEMBL18926592 | 0.80 | BACE1 (0.66) | BACE1APPKCNH2BACE2CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3176172-B1 | SPIROIMIDAZOLE COMPOUNDS AND THEIR USE AS BACE INHIBITORS | ASTRAZENECA AB (SE) | 2020-01-29 | — | — | EP | disclosed |
| EP-3176172-A1 | SPIROIMIDAZOLE COMPOUNDS AND THEIR USE AS BACE INHIBITORS | Astrazeneca AB (SE) | 2017-06-07 | — | — | EP | disclosed |